Pharmacist-Driven Precision Medicine: A Ferry to Cross the Chasm of Interpreting Biomarker Testing Reports

JCO Oncol Pract. 2023 Aug;19(8):679-680. doi: 10.1200/OP.23.00216. Epub 2023 Jun 19.

Authors

Todd C Knepper¹, Theresa A Boyle¹, J Kevin Hicks, Christine M Walko¹

Affiliation

¹ Todd C. Knepper, PharmD, Precision Medicine Program, Department of Individualized Cancer Management, Moffitt Cancer Center, Tampa, FL; Theresa A. Boyle, MD, PhD, Molecular Pathology, Department of Thoracic Oncology, Moffitt Cancer Center, Tampa, FL; J. Kevin Hicks PhD, PharmD and Christine M. Walko, PharmD, Precision Medicine Program, Department of Individualized Cancer Management, Moffitt Cancer Center, Tampa, FL.

PMID: 37335971
DOI: 10.1200/OP.23.00216

No abstract available

Publication types

Letter
Comment

MeSH terms

Biomarkers, Tumor
Humans
Pharmacists*
Precision Medicine*

Substances

Biomarkers, Tumor